Refractory lymphoma treated with chimeric antigen receptor T cells combined with programmed cell death-1 inhibitor: A case report

BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) is a common aggressive non-Hodgkin's lymphoma (NHL), accounting for 30%-40% of adult NHL. Primary testicular (PT) lymphoma is an uncommon extranodal disease representing approximately 1%-2% of lymphoma. Approximately 30%–40% of patients are refr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Cang-Jian, Zhang, Jun-Yu, Li, Lin-Jie, Xu, Neng-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353931/
https://www.ncbi.nlm.nih.gov/pubmed/36157987
http://dx.doi.org/10.12998/wjcc.v10.i21.7502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353931/
https://www.ncbi.nlm.nih.gov/pubmed/36157987
http://dx.doi.org/10.12998/wjcc.v10.i21.7502

Ejemplares similares